13F-HR filed by Birchview Capital, LP
Birchview Capital, LP filed this 13F-HR for the quarter ended 2016-09-30, filed 2016-11-14, with 43 holding rows worth $171,332,000.
- Accession
- 0001618205-16-000017
- Filer
- CIK 1618205
- Filed
- 2016-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2016
A holdings report, 0 entries on the cover page, a total value of $171,332,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $171,332,000 with VALUE read as thousands by filing date, 13F file number 028-16416. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CELGENE CORP | 151020104 | COM | 777,051 | $81,210,000 | thousands by filing date | |
| Accelerate Diagnostics | 00430H102 | COM | 2,175,795 | $59,312,000 | thousands by filing date | |
| VERMILLION INC | 92407M206 | COM NEW | 2,717,514 | $3,533,000 | thousands by filing date | |
| EQT CORP COM | 26884L109 | Stock | 42,300 | $3,072,000 | thousands by filing date | |
| BIOLASE INC | 090911108 | COMMON STOCK | 1,285,903 | $2,250,000 | thousands by filing date | |
| MASIMO CORP COM | 574795100 | Stock | 36,600 | $2,177,000 | thousands by filing date | |
| CONTRAFECT CORP | 212326102 | COM | 725,082 | $1,798,000 | thousands by filing date | |
| ENCANA CORP | 292505104 | COM | 132,300 | $1,385,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 25,200 | $1,276,000 | thousands by filing date | |
| TESARO INC | 881569107 | COM | 9,950 | $997,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 15,000 | $936,000 | thousands by filing date | |
| METABOLIX INC | 591018809 | COM | 2,263,166 | $917,000 | thousands by filing date | |
| QUIDEL CORP | 74838J101 | COM | 38,975 | $861,000 | thousands by filing date | |
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 67,303 | $845,000 | thousands by filing date | |
| ONCOMED PHARMACEUTICALS INC COM | 68234X102 | Stock | 70,689 | $808,000 | thousands by filing date | |
| WRIGHT MED GROUP INC | 98235T107 | COM | 30,000 | $736,000 | thousands by filing date | |
| NXSTAGE MEDICAL INC | 67072V103 | COMMON STOCK | 28,200 | $705,000 | thousands by filing date | |
| SINGLE TOUCH SYSTEMS INC | 82988R203 | COM | 140,000 | $616,000 | thousands by filing date | |
| ACCURAY INC DEL | 004397105 | COM | 95,300 | $607,000 | thousands by filing date | |
| SIENTRA INC | 82621J105 | COM | 63,300 | $569,000 | thousands by filing date | |
| PIONEER NATURAL RESOURCES CO | 723787107 | COM | 3,000 | $557,000 | thousands by filing date | |
| COTERRA ENERGY INC COM | 127097103 | Stock | 21,000 | $542,000 | thousands by filing date | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 80,000 | $520,000 | thousands by filing date | |
| ALDER BIOPHARMACEUTICALS INC | 014339105 | COM | 15,150 | $496,000 | thousands by filing date | |
| QUOTIENT LTD | G73268107 | SHS | 58,200 | $455,000 | thousands by filing date | |
| ADVAXIS INC | 007624208 | COM NEW | 35,600 | $381,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 59,114 | $369,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 1,000 | $313,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 12,300 | $301,000 | thousands by filing date | |
| MERRIMACK PHARMACEUTICALS IN | 590328100 | COM | 44,000 | $279,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 34,567 | $263,000 | thousands by filing date | |
| CELGENE CORP | 151020112 | RIGHT 12/31/2030 | 238,214 | $248,000 | thousands by filing date | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 27,000 | $242,000 | thousands by filing date | |
| WORKHORSE GROUP INC | 98138J206 | COM NEW | 30,000 | $217,000 | thousands by filing date | |
| OPKO HEALTH INC | 68375N103 | COM | 20,202 | $214,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 1,300 | $214,000 | thousands by filing date | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 7,500 | $201,000 | thousands by filing date | |
| GENOCEA BIOSCIENCES INC | 372427104 | COM | 39,000 | $200,000 | thousands by filing date | |
| Medgenics Inc New | 58436Q203 | COM NEW | 34,000 | $189,000 | thousands by filing date | |
| ROKA BIOSCIENCE INC | 775431109 | COM | 252,307 | $175,000 | thousands by filing date | |
| CERUS CORP | 157085101 | COM | 26,500 | $165,000 | thousands by filing date | |
| PARATEK PHARMACEUTICALS INC | 699374302 | Equity | 11,150 | $145,000 | thousands by filing date | |
| Transition Therapeutics, Inc. | 893716209 | COM | 23,866 | $36,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001618205-16-000017 | this filing | 2016-11-14 | acceptance time not in the bulk data set |